Comparison between National Stock Exchange of India IPO and Ujin Pharma IPO.
National Stock Exchange of India IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Ujin Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of National Stock Exchange of India IPO is up to ₹0.00 Cr whereas the issue size of the Ujin Pharma IPO is up to ₹0.00 Cr. The final issue price of National Stock Exchange of India IPO is and of Ujin Pharma IPO is .
| National Stock Exchange of India IPO | Ujin Pharma IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 1,18,69,100 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 14,89,05,525 shares | 72,82,300 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 14,89,05,525 shares | 1,91,51,400 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
National Stock Exchange of India IPO opens on , while Ujin Pharma IPO opens on . The closing date of National Stock Exchange of India IPO and Ujin Pharma IPO is , and , respectively.
National Stock Exchange of India IPO P/E ratio is , as compared to Ujin Pharma IPO P/E ratio of .
| National Stock Exchange of India IPO | Ujin Pharma IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)National Stock Exchange of India Ltd.'s revenue decreased by 2% and profit after tax (PAT) dropped by 15% between the financial year ending with March 31, 2026 and March 31, 2025.
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 32.98 | 12.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 42.80 | 12.54 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.57 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹41.62 | ₹2.60 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 33.21 | 11.87 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the National Stock Exchange of India IPO Retail Individual Investors (RII) are offered 0 shares while in Ujin Pharma IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in National Stock Exchange of India IPO and 0 shares in Ujin Pharma IPO.
| National Stock Exchange of India IPO | Ujin Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
National Stock Exchange of India IPO subscribed in total, whereas Ujin Pharma IPO subscribed .
